🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is designed to compare the effectiveness of the experimental dru...
Status
Completed
Location
Catalina Pointe Clinical Research, Inc.
Start Date
2010-01
Trial ID
NCT01039688
Treatments Being Tested
This is a French prospective longitudinal observational multicentre cohort ...
Status
Recruiting
Location
CHU Amiens Picardie
Start Date
2024-01-25
Trial ID
NCT06089590
Treatments Being Tested
This is a 12 week study that will evaluate the efficacy and safety of the 1...
Status
Completed
Location
Japanese Red Cross Nagoya Daiichi Hospital
Start Date
2014-11-18
Trial ID
NCT02281552
Treatments Being Tested
This study will compare two oral medicines-tofacitinib and methotrexate-for...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-02-15
Trial ID
NCT07406204
Treatments Being Tested
The objectives of this single center, prospective, non-interventional incep...
Status
Unknown
Location
Hanyang University
Start Date
2016-09
Trial ID
NCT03011281
Treatments Being Tested
The goal of this interventional study is to learn, whether Tofacitinib or u...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-07-05
Trial ID
NCT07636057
Takayasu arteritis (TAK) is a rare chronic inflammatory arteritis, which la...
Status
Unknown
Location
Lindi Jiang
Start Date
2020-03-01
Trial ID
NCT04299971
Treatments Being Tested
The aim of this study is to assess the efficacy of upadacitinib, methotrexa...
Status
Active Not Recruiting
Location
Bangabandhu Sheikh Mujib Medical University
Start Date
2025-05-10
Trial ID
NCT07008846
The purpose of this study is to determine the effectiveness and safety, ove...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2007-01
Trial ID
NCT00413660
Treatments Being Tested
This study \[contRAst 1 (201790: NCT03980483)\] is a phase 3, randomized, m...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-05-16
Trial ID
NCT03980483
Treatments Being Tested